Answers are grounded in this paper and cite their sources.
Background: The efficacy of Dexamethasone as a method of conservative management for CSDH to avoid surgery remains inconclusive even after "Dex-CSDH" randomized controlled trial as almost all patients underwent an initial operation to remove the hematoma.Current study aims to determine the efficacy and safety of Dexamethasone alone therapy in comparison with the surgical drain of CSDH.Methods: A multicenter, prospective study on mild to moderately symptomatic adult patients with CSDH were performed from January 2019 to December 2020.The patients were enrolled in a 1:1 ratio to receive a 3-weeks tapering course of oral Dexamethasone, starting at 4 mg thrice daily, or surgical drain of CSDH.The patient was assigned to a particular therapy based on their preference.The primary outcome was functional outcome in each group at 6 months determined by mRS, and cure rate (symptomatic relief and radiological resolution of CSDH).Results: Twenty eights patients were assigned to Dexamethasone group and 30 patients to surgical group.The mean age of the patient was about 62 years in both groups with male predominance (>60%).A favorable outcome determined by mRS scale of 1 to 3 at 6 months follow-up was 25/28 (89.2%) in Dexamethasone group compared to 28/30 (93.3%) in surgical group (difference, -4.1 [95% CI, -6.8 to -2.2], p=0.12).The cure rate was 23/28 (82.1%) in Dexamethasone group compared to 28/30 (93.3%) in the surgical group during index admission (difference, -11.2, [95% CI, -14.3 to -7.6] in favor of the surgical group, p=0.005).Recurrence rate for CSDH was 2/28 (7.1%) in Dexamethasone group compared to surgical group 4/30 (13.3%) which was statistically significant (p=0.01).Morbidity related to medical therapy was not statistically higher compared to surgical group.Conclusion: Current study exhibits superiority of surgery over Dexamethasone therapy for resolution of symptomatic CSDH.The recurrence rate of CSDH is lower in patients with corticotherapy compared to surgical drain.Patients in Dexamethasone group did not have functional outcome at 6 months or morbidity significantly higher than surgical group.This study strongly puts forward the utility of Dexamethasone as an effective and safe alternative to surgery for CSDH.
No takes yet. Share an insight, caveat, or question.
Abhishek Chaturbedi (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: